Friday, 6 September 2013

Novartis signs deal to boost cell therapy portfolio

ZURICH (Reuters) - Swiss drugmaker Novartis AG said on Friday it had signed a licensing and research deal that could boost its ability to develop innovative cell-based therapies for conditions where little treatment is currently available.


via Reuters: Health News Read More Here..

No comments:

Post a Comment